Plavix ruling upheld
Executive Summary
U.S. Court of Appeals for the Federal District has upheld the district court ruling that the Plavix (clopidogrel) patent is valid and enforceable, maintaining protection until November 2011 (1"The Pink Sheet" Aug. 4, 2008, p. 19). Sanofi-Aventis and Bristol-Myers Squibb are seeking damages from Apotex, which launched a generic for part of 2006